Development of Sars-CoV-2 MPro protease inhibitors as 'direct-acting antivirals' for the pharmacological treatment of coronavirus infections
identifier: ASS_NAZ23ALAI_01
most specific type: Project
type: Thing
type: Entity
type: Process
type: Project
type: Occurrent
ARG_2000028: ASS NAZ23ALAI 01

Entity
type: Class

Process
type: Class

individual
rights: termsOfUse
date: 2026-08-03T06:02:49
publisher: Development of Sars-CoV-2 MPro protease inhibitors as 'direct-acting antivirals' for the pharmacological treatment of coronavirus infections
type: Document
label: RDF description of Development of Sars-CoV-2 MPro protease inhibitors as 'direct-acting antivirals' for the pharmacological treatment of coronavirus infections - http://irises.unimi.it/resource/project/ASS%5FNAZ23ALAI%5F01

Project
type: Class

Occurrent
type: Class